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Abstract
Background: Helicobacter pylori forms biofilms on glass surfaces at the air-liquid interface in in vitro
batch cultures; however, biofilms of H. pylori have not been well characterized. In the present study,
we analyzed the ability of H. pylori strains to form biofilms and characterized the underlying
mechanisms of H. pylori biofilm formation.
Results: Strain TK1402 showed strong biofilm forming ability relative to the other strains in
Brucella broth supplemented with 7% FCS. The strong biofilm forming ability of TK1402 is reflected
the relative thickness of the biofilms. In addition, outer membrane vesicles (OMV) were detected
within the matrix of only the TK1402 biofilms. Biofilm formation was strongly correlated with the
production of OMV in this strain. We further observed that strain TK1402 did not form thick
biofilms in Brucella broth supplemented with 0.2% β-cyclodextrin. However, the addition of the
OMV-fraction collected from TK1402 could enhance biofilm formation.
Conclusion: The results suggested that OMV produced from TK1402 play an important role in
biofilm formation in strain TK1402.
Background
Helicobacter pylori is a spiral, microaerophilic, noninva-
sive, gram-negative bacterium that colonizes the human
gastrointestinal tract, primarily the stomach [1]. This
organism has been identified as an aetiological agent of
chronic active gastritis, peptic ulcer disease [2,3], gastric
adenocarcinoma [4], and mucosa-associated lymphoid
tissue (MALT) lymphoma [5]. A number of factors such as
the VacA cytotoxin, the cag pathogenicity island (cag PAI),
motility, and the urease enzyme are known to be involved
in the virulence of this organism [6-8].
Biofilm development is initiated when bacteria transit
from a planktonic state to a lifestyle in which the microor-
ganisms are firmly attached to biotic or abiotic surfaces,
and biofilms are strongly implicated in bacterial virulence
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[9]. Biofilm formation is critical not only for environmen-
tal survival but also for successful infection by numerous
pathogenic bacteria. Among human bacterial pathogens,
the biofilms of Pseudomonas aeruginosa, Haemophilus influ-
enzae, pathogenic Escherichia coli, Vibrio cholerae, staphylo-
cocci and streptococci are some of the best studied [10-
14]. Bacterial biofilms are frequently embedded in a self-
produced extracellular matrix [15]. The extracellular poly-
meric substance (EPS) matrix, which can constitute up to
90% of the biofilm biomass, is a complex mixture of
exopolysaccharides, proteins, DNA and other macromol-
ecules [16].
Previous studies have alluded to the ability of H. pylori to
form biofilms [17,18]. A polysaccharide-containing bio-
film has been observed at the air-liquid interface when H.
pylori was grown in a glass fermenter [17]. H. pylori is also
capable of binding to a heterotrophic mixed species bio-
film grown on stainless steel coupons [18]. Recent studies
indicated that 10 strains including some animal-adapted
strains, clinical isolates and laboratory strains, were able
to form similar three-dimensional architectures impli-
cated in biofilm development [19,20]. Cellini et al.
reported that an environmental H. pylori strain, named
MDC1, displayed a well structured biofilm [19]. Cole et al.
also indicated that mucin greatly accelerated planktonic
growth relative to the expansion of H. pylori biofilms [2].
In addition, a recent study indicated that H. pylori can exist
in human gastric mucosa forming biofilms [21]. These
studies indicated that the topic of biofilm formation in
this organism has the potential to contribute to our
knowledge of H. pylori pathogenesis. However, little is
known regarding the mechanism of H. pylori biofilm
development. In the present study, we characterized the
ability of 4 reference strains and 4 clinical isolates of H.
pylori to form biofilms. Furthermore, we investigated the
potential role of outer membrane vesicles (OMV) released
from this organism in biofilm development.
Results
Biofilm formation by H. pylori strains
We attempted to grow biofilms of the 8 strains of H. pylori
on glass coverslip surfaces in Brucella broth supplemented
with 7% FCS with shaking for 3 days or 5 days and found
that all strains formed biofilms at the liquid-gas interface
of the cultures. Under these conditions, all of the strains
except strain TK1402 formed relatively little biofilm bio-
mass (Fig. 1A). In contrast, the clinically isolated strain
TK1402 showed significantly higher levels of biofilm for-
mation (Fig. 1A). The growth yields of these strains for 3-
or 5-days of culturing were comparable for all of the
strains (Fig. 1B). To determine the kinetics of H. pylori bio-
film formation, strains TK1402 and SS1 were assessed for
biofilm forming ability and growth rates from day 1 to
day 6 (Fig. 1C and 1D). Both strains showed similar
growth kinetics with both strains fully grown within 2
days although the maximum titers of strain SS1 were
slightly lower compared to that of strain TK1402. After 3
days of incubation, the growth yields were slightly
decreased and plateaued at day 6. On the other hand, bio-
film formation by strain TK1402 increased until day 3
(Fig. 1C). After 3 days of incubation, biofilm formation
reached a plateau up to day 6. Biofilm formation by strain
SS1 was not significantly different from day 1 to day 3
(Fig. 1D), and biofilm formation was significantly lower
than that of TK1402 upon cultivation for up to 6 days.
Morphological analysis of biofilms
The biofilms were stained with a BacLight LIVE/DEAD
bacterial viability kit solution which could differentiate
between live cells (green) and dead cells (red). Strain
TK1402 formed strong biofilms covering the entire visible
area (Fig. 2A) but the other strain SS1 formed relatively
poor biofilms (Fig. 2B). In the biofilms of both strains, the
majority of the biofilm cells were stained green (Fig. 2A,
and 2B). In order to confirm that the TK1402 biofilm cells
were viable, the 2-day and 3-day biofilms cells were
scrapped into PBS and the optical densities and the CFU
values of the mixtures were evaluated (Table 1). The 2-day
and 3-day cultures of this strain in Brucella broth supple-
mented with 7% FCS were also measured as controls. The
optical densities and CFU of the 3-day biofilm cells
showed increases compared to those of 2-day biofilm
cells. Further, the CFU values were normalized to optical
densities. The values for the 2-day biofilm cells were sim-
ilar compared to the controls (broth culture). However,
the normalized values for 3-day biofilm cells tended to be
decreased, although there was no significant difference in
the normalized values, suggesting that 3-day biofilm cells
might contain some dead cells or morphologically altered
cells.
Next we analyzed the biofilm thickness of strains TK1402,
SS1, TK1029, and ATCC 49503 with CMLS observations.
Strain TK1402 exhibited 2-fold or greater biofilm thick-
ness compared to the other strains (Fig. 2C). To clarify the
architectural characteristics of H. pylori biofilms, we com-
pared TK1402 and SS1 biofilms by SEM analysis. In the
biofilms of strain SS1, the bacteria attached to glass sur-
faces in thin layers (Fig. 2E). Interestingly, the biofilms
consisted mainly of bleb-like or amorphous structures.
On the other hand, the TK1402 biofilms were composed
primarily of cells with bacillary morphology which were
clearly outlined (Fig. 2D). In addition, these later bacteria
showed layer formation with bacterial aggregates in the
biofilms. The biofilm bacterial aggregates appeared to
result from direct cell-cell attachment. Intriguingly,
TK1402 biofilms showed the presence of many OMV-like
structures on the glass surface as well as on the bacterial
cell surfaces (Fig. 2D, white arrows). These structures wereBMC Microbiology 2009, 9:197 http://www.biomedcentral.com/1471-2180/9/197
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not detected in the biofilms of the other strains (Fig. 2E
and data not shown). A recent report indicated that OMV
production from H. pylori clinical isolate MDC1 was
apparent under SEM observation [19]. We thus decided to
focus our attention more on the OMV-like structures in
subsequent experiments.
Potential role of the OMV in TK1402 biofilm formation
We observed more closely the OMV-like structures in the
thin-sectioned biofilms using TEM (Fig. 3). These struc-
tures consisted primarily of bilayered proteolipids which
were mainly spherical in shape (Fig. 3, black arrows).
These structures also exhibited the characteristics typical
of Gram negative bacterial OMV [22]. We confirmed that
the OMV-fraction did not contain flagella by observation
with SM and Western blotting with anti-flagella antibody.
We next found that the FCS concentration in the biofilm
growing medium affected biofilm formation of H. pylori
TK1402 (Fig. 4A). The lower concentrations of FCS (3.5%,
(A) Biofilm formation by eight H. pylori strains Figure 1
(A) Biofilm formation by eight H. pylori strains. The graph shows quantification of biofilms formed after 3-days (white 
bars) and 5-days (black bars) following culture in Brucella broth containing 7% FCS. (B) Eight H. pylori strains were grown in 
Brucella broth containing 7% FCS-, and OD600 absorbance was measured at 3-days (white bars) and 5-days (black bars). (C, and 
D) Time course experiments for the H. pylori strains TK1402 (C) and SS1 (D) biofilm formation and their growth. The biofilm 
mass of these strains are shown as black bars and the lines depict the OD600 absorbances of these strains. All of the results 
were expressed as the means ± standard deviations from at least three independent experiments. *significantly different (p < 
0.05) relative level of biofilm formation (strain TK1402 versus other strains).BMC Microbiology 2009, 9:197 http://www.biomedcentral.com/1471-2180/9/197
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1.75% or 0) caused a significant decrease in biofilm for-
mation in this strain compared to that in 7% FCS. There-
fore, the intensity of biofilm formation was dependent
upon the concentration of FCS. The OMV were isolated
from the cells under these conditions and characterized by
SDS-PAGE (Fig. 4B). As the components of FCS might be
present in the OMV fraction, the control fractions from
Brucella broth supplemented with various concentration
of FCS (7%, 3.5% 1.75% and 0) without the microorgan-
ism were used as controls. There were many protein bands
which did not conform to FCS components (Fig. 4, lanes
1 to 4 vs. lanes 5 to 8). To quantify the production of OMV
under these conditions, the OMV-fractions were analyzed
by Western blotting with anti-H. pylori strain NCTC 11638
antibody. There were many positive bands and the inten-
sity of these bands correlated with the FCS concentrations
(Fig. 4C). As a negative control, control fractions from
Brucella broth supplemented with 7% FCS without the
microorganism were used and there were no detectable
corresponding bands (Fig. 4C, lane 5). In addition, we
observed the biofilms under these conditions with SEM
(Fig. 4D to 4G). There were no OMV in the biofilms of
Brucella medium only (Fig. 4D). In contrast, a large
number of the OMV were detected in biofilms in Brucella
broth supplemented with 7% FCS (Fig. 4G). Under these
conditions, the quantity of the OMV in the biofilm
appeared to be dependent upon the concentration of FCS
(Fig. 4D to 4G). These results suggested that the produc-
tion of OMV might be related to the biofilm forming abil-
ity of strain TK1402.
We further determined that 3-day biofilm formation with
strain TK1402 in Brucella broth supplemented with 7%
HS or 0.2% β-cyclodextrin was significantly weaker than
that in Brucella broth supplemented with 7% FCS (Fig.
5A). Other strains, which form thin biofilms in Brucella
broth supplemented with 7% FCS, also formed weaker
biofilms, similar to or weaker than those in FCS broth
with either horse serum or β-cyclodextrin. The final densi-
ties of strain TK1402 evaluated by OD600 units after 3 days
of culture were 0.96 ± 0.09, 1.11 ± 0.19, and 0.87 ± 0.13
following growth with Brucella broth supplemented with
7% FCS, 7% HS, or 0.2% β-cyclodextrin, respectively. We
then isolated the OMV from TK1402 cultured in Brucella
broth containing 7% FCS, 7% HS, or 0.2% β-cyclodextrin
and Western blotting with the anti-H. pylori antibody was
carried out (Fig. 5C). The 50- to 60-kDa OMV protein
band intensities from growth in Brucella broth supple-
mented with 7% FCS were much greater than comparable
fractions from 7% HS or 0.2% β-cyclodextrin-grown cul-
tures. These results suggested that lower production of
OMV might lead to weaker biofilm formation in Brucella
broth supplemented with 7% HS or 0.2% β-cyclodextrin.
To directly verify that the OMV were components of the
TK1402 biofilm matrix and that the production of the
OMV can induce strong biofilm formation, TK1402 bio-
film formation with 0.2% β-cyclodextrin medium was
analyzed following the addition of the OMV fraction from
TK1402 cultures in Brucella broth containing 7% FCS. The
protein concentration of the OMV-fraction was adjusted
to 2.0 mg/ml or 1.0 mg/ml. The OMV fraction (total
amounts were 0.2 mg or 0.1 mg, respectively) was added
to Brucella broth with 0.2% β-cyclodextrin and biofilm
formation with strain TK1402 was carried out. As the
components of FCS might be present in the OMV fraction
and could affect biofilm formation, a control fraction
from Brucella broth supplemented with 7% FCS without
the microorganism was used. The levels of biofilm forma-
tion in the 0.2% β-cyclodextrin medium supplemented
with the control OMV fraction was similar to that of the
0.2% β-cyclodextrin medium alone (Fig. 5B, lane β-cyclo-
dextrin-control). On the other hand, the addition of the
0.1 mg OMV fraction from TK1402 showed significantly
higher levels of biofilm formation than those in 0.2% β-
cyclodextrin medium with the control fraction (Fig. 4B, β-
cyclodextrin-FCS OMV 0.1). The levels of biofilm forma-
tion with OMV addition were similar to that in Brucella
broth supplemented with 7% FCS (Fig. 4B. β-cyclodex-
trin-FCS OMV 0.2). We further determined that the 0.1
mg OMV fraction from H. pylori cultured in Brucella broth
containing 0.2% β-cyclodextrin could also enhance bio-
film formation but at levels lower than 0.2 mg of this frac-
tion. The OMV fraction induced more biofilm formation
than 0.1 mg of the OMV fraction from 7% FCS medium
(Fig. 5B, β-cyclodextrin-β-cyclo OMV 0.1).
Table 1: Optical densities and CFU measurements in the strain TK1402 biofilm cells and broth cultures
OD600 CFU (×109)C F U / O D 600 (×109)
2-Day biofilma 0.141 ± 0.037 0.259 ± 0.202 1.860 ± 1.487
3-Day biofilma 0.258 ± 0.027 0.340 ± 0.230 1.614 ± 0.695
2-Day broth cultureb 0.939 ± 0.012 1.847 ± 0.318 1.966 ± 0.387
3-Day broth cultureb 1.075 ± 0.044 2.248 ± 1.170 2.151 ± 1.180
a) the biofilm cells were scrapped by mechanical treatment into PBS. The cell suspensions were examined by optical densities and CFU were also 
calculated.
b) the standard broth cultures of strain TK1402 in Brucella broth supplemented with 7% FCS were examined by optical densities and CFU.
Data are shown as the mean value of the 3-independent experiments ± standard deviations.BMC Microbiology 2009, 9:197 http://www.biomedcentral.com/1471-2180/9/197
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CLSM images of H. pylori strains TK1402 (A) and SS1 (B) biofilms in Brucella broth containing 7% FCS Figure 2
CLSM images of H. pylori strains TK1402 (A) and SS1 (B) biofilms in Brucella broth containing 7% FCS. Each 
image represents the layer in the Z-stack that has the maximum bacterial coverage. The 3-day biofilms of each strain were 
stained with BacLight LIVE/DEAD stain. Viable cells are colored green and nonviable cells are colored red. x-z and y-z recon-
structions of each biofilm are shown on the right and upper sides of each x-y image. The scale bars equal 50 μm in both panels. 
(C) Biofilm thickness of each strain. Each biofilm was scanned with CLSM at five randomly selected positions and x-z color 
detection, corresponding to biofilm thickness, was determined throughout the height of the biofilm. Data are representative of 
three independent experiments. The results are expressed as the means ± standard deviations. SEM images of H. pylori strains 
TK1402 (D) and SS1 (E) biofilms in Brucella broth containing 7% FCS. The 3-day biofilm of each strain on cover glass was inves-
tigated using SEM. The OMV-like structures are indicated by white arrows (D). Scale bars (2 μm) are shown at the bottom of 
each electron micrograph. *significantly different relative levels of biofilm thickness (p < 0.05; strain TK1402 versus other 
strains).BMC Microbiology 2009, 9:197 http://www.biomedcentral.com/1471-2180/9/197
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Evaluation of biofilm formation by other isolated H. pylori 
strains
In order to detect other strains having similar biofilm
forming ability to strain TK1402, we assessed the biofilm
forming ability of ten additional clinical isolates of H.
pylori. Only strain TK1049 showed similar levels of bio-
film formation to that of strain TK1402 (Fig. 6A). The
other strains showed lower levels of biofilm formation
than strain TK1402 (the biofilm OD595 values ranged
from 0.1 to 0.3). The structure of TK1049 biofilms was
then observed by using SEM (Fig. 6C). Cellular aggrega-
tion was observed to be similar to that of TK1402 biofilms
and many vesicle-like structures were also detected with
TK1409. Moreover, 3-day biofilm formation with strain
TK1049 in Brucella broth supplemented with 0.2% β-
cyclodextrin was weaker than that in Brucella broth sup-
plemented with 7% FCS. However, the addition of the
OMV fraction from TK1402 in Brucella broth supple-
mented with 0.2% β-cyclodextrin restored biofilm forma-
tion similar to that in Brucella broth supplemented with
7% FCS (Fig. 6B).
Discussion
In this study, we characterized biofilm formation in H.
pylori  strains and demonstrated differential abilities to
form biofilms in reference and clinical isolates. In addi-
tion, the production of OMV in strain TK1402 was corre-
lated with strong biofilm formation. Several reports
indicated that H. pylori has the ability to form biofilms on
abiotic surfaces in vitro as well as on human gastric
mucosa [18-21,23]. The results of the biofilm formation
analyses demonstrated that strain TK1402 has strong bio-
film forming ability compared to other strains independ-
ent of its growth rate. Development of strain TK1402 and
SS1 biofilms from day 1 to day 6 demonstrated that it
took 3 days for biofilm maturation under these condi-
tions, suggesting that H. pylori biofilm formation might
proceed in an organized fashion through early (Day 1),
intermediate (Day 2) and maturation (after Day 3) phases
of development. Similar distinct developmental phases
have been reported for biofilm formation by other bacte-
rial species [24,25]. Since development of biofilms is
closely associated with the generation of a matrix, the
majority of which is extracellular material, biofilm devel-
opment in H. pylori appears to share common basic steps
with other biofilm forming bacteria.
The biofilm forming cells at day 3 generally appeared to
be viable when the cells were exposed to Live/Dead
BacLight staining. In addition, the normalized CFU values
for the biofilm and broth culture cells following 2 days of
incubation were comparable. In 3-day biofilm cells, this
value was slightly decreased compared to 3-day broth cul-
ture cells, suggesting the presence of some dead cells in
the biofilm. These results are consistent with the matura-
tion phase of the development of biofilms in 3-day bio-
films of strain TK1402, since biofilms are thought to be
encased in an EPS matrix as well as dead cells [26]. In
addition, strain TK1402 exhibited thick biofilm forma-
tion. The biofilm morphology of strain TK1402 showed
direct cell-cell bound aggregates as well as flagella-
dependent binding forms. The cell-cell interacting forms
might act as precursors for thick biofilm formation. Gots
et al. indicated that cell-cell aggregation induces a multi-
layered architecture during Staphylococcus epidermidis bio-
film formation [27]. Moreover, in our SEM observations,
for the majority of the H. pylori strains examined, ie., SS1,
biofilms may contain autolysed cells. On the other hand,
there were clearly intact cells in TK1402, as well as
TK1049, biofilms and the later is also another strong bio-
film forming strain. These observations suggested that
these strong biofilm forming strains may remain in an
active metabolic state for a relatively long time without
exhibiting morphological changes or autolysis, in com-
parison with the other strains. These later properties could
be responsible for the weaker biofilm forming activities of
most of the strains examined in this study.
In the SEM observations of TK1402 biofilms, there were
many OMV. OMV production is a physiologically normal
function of gram-negative bacteria [22,28]. It was also
reported that the H. pylori strains released OMV into the
extracellular space [29,30]. A recent report indicated that
OMV were a component of the matrix of P. aeruginosa bio-
TEM images of H. pylori strain TK1402 biofilms in Brucella  broth supplemented with 7% FCS Figure 3
TEM images of H. pylori strain TK1402 biofilms in 
Brucella broth supplemented with 7% FCS. The 3-day 
biofilm of strain TK1402 on glass slides was investigated by 
using TEM.BMC Microbiology 2009, 9:197 http://www.biomedcentral.com/1471-2180/9/197
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(A) Effects of FCS concentrations in the biofilm growth medium on TK1402 biofilm formation Figure 4
(A) Effects of FCS concentrations in the biofilm growth medium on TK1402 biofilm formation. Strain TK1402 
biofilms in Brucella broth supplemented with various concentrations of FCS (7%: lane 1, 3.5%: lane 2, 1.75%: lane 3 and 0: lane 
4) were examined. Quantification of biofilms (percent) was calculated relative to that of strain TK1402 in Brucella broth sup-
plemented with 7% FCS, which was set equal to 100%. The values for the biofilms under these conditions are shown as in Fig. 
1A. (B) The OMV were fractionated from different medium conditions for TK1402 cultures and the OMV-fractions were sep-
arated by SDS-PAGE (lane 1, 7% FCS; lane 2, 3.5%; lane 3, 1.75% lane 4, Brucella broth only) and compared to controls 
(medium without the organism, FCS concentrations were 7%: lane 5, 3.5%: lane 6, 1.75%: lane 7 and 0: lane 8). (C) Western 
blotting of OMV-fraction from different medium conditions using anti-H. pylori antibody. M: Molecular weight marker. Lanes: 1, 
7% FCS; 2, 3.5%; 3, 1.75%; 4, 0; 5, 7% FCS without organism (negative control). (D to G) SEM observation of TK1402 biofilms 
under different medium conditions. D: Brucella broth only (without FCS, 0); E: with 1.75% FCS; F: with 3.5% FCS; G: with 7% 
FCS. *significantly different (p < 0.05). ** significantly different (p < 0.005).BMC Microbiology 2009, 9:197 http://www.biomedcentral.com/1471-2180/9/197
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films [14]. We analyzed thin-sections of strain TK1402
biofilms with TEM. The OMV were located at the substra-
tum-bacterium interface and extracellular space. Interest-
ingly, some of OMV appeared to be involved in attaching
one cell with another. This observation suggested that the
OMV produced by strain TK1402 could be intimately
involved in biofilm formation.
Previously, several reports indicated that VacA, urease and
lipopolysaccharides are present on the surface of OMV
from H. pylori along with other outer membrane proteins
[29,30]. We quantified OMV production in Brucella broth
supplemented with various concentration of FCS using
Western blotting with anti-H. pylori antibody. Moreover,
the SEM observations were also carried out to directly con-
firm this. The FCS concentration in the biofilm medium
showed a direct positive correlation with OMV produc-
tion as well as biofilm forming ability. Further, similar
results were detected by the addition of serum from differ-
ent hosts as well as with synthetic substrates. On the other
hand, observation with biofilm forming bacteria indi-
cated that LPS plays a role in biofilm development and
architecture [14,31]. Recently, Keenan et al. reported that
LPS detected in OMV under iron-limited conditions were
(A) Biofilm formation by strain TK1402 in Brucella broth supplemented with 7% FCS (-FCS), 7% HS (-HS), or with 0.2% β- cyclodextrin (-β-cyclodextrin) Figure 5
(A) Biofilm formation by strain TK1402 in Brucella broth supplemented with 7% FCS (-FCS), 7% HS (-HS), or 
with 0.2% β-cyclodextrin (-β-cyclodextrin). Relative biofilm forming activity (percent) was calculated relative to the 3-day 
biofilm in Brucella broth supplemented with 7% FCS. Data are expressed as the means of all of experiments ± standard devia-
tions. (B) The OMV-fraction was added to Brucella broth supplemented with β-cyclodextrin. The protein concentrations in the 
OMV-fractions were adjusted and 0.2 mg of the OMV-fraction (β-cyclodextrin-FCS OMV 0.2), or 0.1 mg of the OMV-fraction 
(β-cyclodextrin-FCS OMV 0.1) were added. Control fractions from the medium without bacteria were also added (β-cyclo-
dextrin-control). Further, the OMV-fraction was isolated from this organism in Brucella broth supplemented with 0.2% β-
cyclodextrin and 0.1 mg of the OMV-fraction from 0.2% β-cyclodextrin medium was added (β-cyclodextrin-β-cyclo OMV 0.1). 
Biofilm formation was examined after 3 days of culture. Relative biofilm forming activity (percent) was calculated relative to the 
3-day biofilm in Brucella broth supplemented with 7% FCS. Data are expressed as the means of all of experiments ± standard 
deviations. (C) Western blotting of the OMV-fraction from different medium conditions using anti-H. pylori antibody. M: Molec-
ular weight marker. Lanes: 1, 7% FCS; 2, 7% HS; 3, 0.2% β-cyclodextrin. *significantly different (p < 0.05). ** significantly differ-
ent (p < 0.005).BMC Microbiology 2009, 9:197 http://www.biomedcentral.com/1471-2180/9/197
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notably shorter than those under iron-replete conditions
[32]. We hypothesize that strain TK1402 has an altered
LPS, particularly LPS O-antigens under different experi-
mental conditions including the use of different animal
sera, synthetic substrates, or different FCS concentrations.
To confirm this, we analyzed the LPS profiles of H. pylori
cultured in different culture media by SDS-PAGE and sil-
ver staining. However, there were no differences in the
LPS O-antigen profiles. We then isolated the OMV from
the TK1402 culture supernatant in order to examine the
role of these structures in biofilm formation. Biofilm for-
mation by this strain was increased following the addition
of the OMV-fraction in a dose-dependent manner.
Although the quantities of OMV added were three- to five-
fold more than the quantity of the OMV which exist in
biofilms under our experimental conditions, the OMV
appear to play an important role in the formation of the
extracellular matrix of strain TK1402 biofilms. The extra-
cellular matrix serves a role in bacterial attachment to abi-
otic and cellular surfaces in the initial stage of biofilm
formation [33]. It is possible that specific proteins in the
OMV released from strain TK1402 may take part in bacte-
rial aggregation and biofilm formation. Which compo-
nent(s) of the OMV contribute to biofilm formation still
remains to be determined. Additional investigations are
now in progress to determine such components in the
OMV.
In the present study, we searched for other clinical isolates
with strong biofilm formation and one strain, TK1049,
exhibited similar ability to form biofilms as strain
TK1402. This suggested that H. pylori strains exhibiting
strong biofilm forming ability are relatively rare. Indeed,
Williams et al. indicated that FCS inhibited adherence to
abiotic surfaces in some of the H. pylori strains [34]. This
apparent discrepancy between their study and our present
results in terms of the effects of FCS might be due to dif-
ferences in the H. pylori strains used.
Strain TK1402 was isolated from a patient with duodenal
and gastric ulcers in Japan. This strain contains the cagA,
cagPAI and vacA genes as demonstrated by PCR [35]. It
was also shown that this strain expresses the Lewisy anti-
gen (LeY) on the cell surface. Moreover, strain TK1402
was reported to exhibit virulence in gnotobiotic mice [36],
C57BL mice [37], and Mongolian gerbils [35]. These
(A) Biofilm formation by strain TK1049 Figure 6
(A) Biofilm formation by strain TK1049. Graph shows quantification of biofilms formed after 3-day (Day 3) and 5-days 
(Day 5) in Brucella broth supplemented with 7% FCS. (B) Biofilm formation by strain TK1049 in Brucella broth supplemented 
with 0.2% β-cyclodextrin and addition of the OMV-fraction from TK1402 grown in 0.2% β-cyclodextrin medium. (C) SEM 
observation of TK1049 biofilms. *significantly different (p < 0.05).BMC Microbiology 2009, 9:197 http://www.biomedcentral.com/1471-2180/9/197
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reports indicated that the TK1402 strain has the ability to
colonize the stomach of these animals as well as in
humans. These results as well as our present findings sug-
gest that this colonization ability might be correlated with
the strong biofilm forming ability of strain TK1402.
Therefore, we speculate that strong biofilm forming abil-
ity is related to gastric colonization by H. pylori in various
animals as well as in humans. It is recognized that an
understanding of H. pylori biofilm formation is still in its
infancy. The ability of H. pylori strains, as exemplified by
strain TK1402, to form biofilms may play a part of role in
the infectious process.
Conclusion
We have demonstrated that strain TK1402 has strong bio-
film forming ability. In addition, the results suggested that
this property is dependent upon direct cell-cell binding
mediated by the OMV of this strain. This represents a new
observation relative to a potentially novel gastric cell col-
onization factor of this organism.
Methods
Bacterial strains and culture conditions
The following H. pylori strains were used: SS1, ATCC
49503, ATCC 43579, NCTC11638, TK1029, TK1402,
KR2003, and KR2005. The last four are clinical isolates
from Japanese patients. Strains TK1029 and TK1402 were
used as described previously [38]. In addition, strains
TK1036, TK1042, TK1043, TK1045, TK1046, TK1047,
TK1049, TK1054, TK1056, and TK1057 were also used for
assessing biofilm forming ability. Strains KR2003 and
KR2005, as well as the latter strains were isolated from a
gastritis patient in our laboratory. All strains were main-
tained at -80°C in Brucella broth (Difco, Detroit, Mich)
with 20% (vol/vol) glycerol. These strains were cultured
under microaerobic conditions at 37°C on Brucella agar
plates containing 7% horse serum (HS).
Biofilm formation and its quantification
Biofilm formation by all strains was carried out as previ-
ously described [19,20] with slight modifications. Briefly,
sterilized glass coverslips (approximately 22 × 22-mm,
0.12 to 0.17-mm thickness, Matsunami Glass, Tokyo,
Japan) were placed into 12-well microtiter plates. Each
well was filled with 2 ml of Brucella broth supplemented
with 7% fetal calf serum (FCS), 7% horse serum (HS), or
0.2% β-cyclodextrin to allow adherence of H. pylori at the
air-liquid interface. The formation of biofilms was initi-
ated by inoculating 10 μl of pre-cultured cell suspension
(approximately 5 × 105 cells in Brucella broth) into each
well. The cultures were incubated under microaerobic
conditions at 37°C for 1 to 6 days with shaking (80-100
rpm). After incubation, the coverslips were removed and
washed with phosphate-buffered saline (PBS). The sam-
ples were then air dried and stained with crystal violet for
30 s. After being stained, the coverslips were rinsed with
distilled H2O to remove excess dye and then air dried for
30 min. All dye associated with the biofilms was dissolved
with 1 ml of ethanol and 200 μl of the ethanol solutions
were used to measure the absorbance at 594 nm with a
microplate reader to determine the amount of biofilm for-
mation.
Confocal laser scanning microscopy (CLSM) and 
measurement of biofilm thickness
For visualization, the biofilms of H. pylori strains on the
coverslips were stained with a BacLight LIVE/DEAD bacte-
rial viability kit solution (Molecular Probes, Leiden, The
Netherlands) according to the directions of the supplier.
Confocal images were collected by using a Zeiss LSM 510-
META confocal laser scanning microscope (Carl Zeiss,
Jena, Germany). To determine biofilm thickness, a series
of horizontal (xz) optical sections at 0.5 μm intervals were
taken through the height of the biofilm for measurement.
Each biofilm was scanned at five randomly selected posi-
tions. Each sample was observed independently more
than three times. Confocal images of green and red fluo-
rescence were constructed simultaneously using a multi-
track mode.
Cell viability assay
To determine the numbers of viable bacteria, biofilm cells
on the coverslips were scrapped into PBS. The optical den-
sities and colony-forming units (CFU) of the cell suspen-
sions were quantitated as the mean of three independent
observations. As controls, standard cell broth cultures
were used.
Electron microscopic studies
To observe the biofilm ultrastructure, the biofilms formed
on the coverslips were examined by scanning electron
microscopy (SEM). The biofilms on the coverslips were
fixed with 2% glutaraldehyde for 3 h at room temperature
and the samples were observed using a JSM-5600LV elec-
tron microscope (JEOL, Tokyo, Japan).
To observe the OMV-like structures, the biofilms of strain
TK1402 on the glass slides were examined by using trans-
mission electron microscopy (TEM). Glass slides cut in
half were placed into 6-well microtiter plates and the bio-
films were allowed to form as described above. The bio-
films were fixed with 2% glutaraldehyde for 3 h at room
temperature. The samples were then dehydrated and
embedded in Epon 813 embedding solution (Chemische
Werke Lowi GmbH, Waldkaraigurg, Germany). The sec-
tions were finally observed with a JEM-100 electron
microscope (Jeol).
Isolation of outer membrane vesicles
Isolation of OMV was performed as described previously
[30]. Briefly, H. pylori strain TK1402 was grown in Brucella
broth supplemented with various concentration of FCSBMC Microbiology 2009, 9:197 http://www.biomedcentral.com/1471-2180/9/197
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for 3 days. After cultivation, the optical density at 600 nm
of the cell cultures was adjusted to 0.5 with each respective
medium. The cells were collected by centrifugation
(10,000 g for 15 min), and the resulting supernatants
were filtered (low protein binding Durapore membrane,
0.45 mm polyvinylidene fluoride, Millipore, Bedford,
Mass.). The filtrates were centrifuged (40,000 g, 2 h at
4°C), washed with PBS and re-centrifuged (40,000 g, 2 h
at 4°C). The pellets were next resuspended in PBS supple-
mented with 0.2 M NaCl. The media without the bacteria
were used as controls. The OMV of strain TK1402 in Bru-
cella broth supplemented with 0.2% β-cyclodextrin or 7%
horse serum were also isolated in a similar manner.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) and immunoblotting techniques
The fractionated OMV (OMV-fraction) were treated with
sodium dodecyl sulfate (SDS) loading buffer including
5% 2-mercaptoethanol at 100°C for 5 min and separated
by polyacrylamide gel electrophoresis (PAGE). The sepa-
rated OMV proteins were stained with Coomassie brilliant
blue. For Western blotting assays, the OMV-fractions were
loaded onto gels and transferred to polyvinylidene diflu-
oride membranes (Atto, Tokyo, Japan). After transfer, the
membranes were blocked with 3% bovine serum albumin
in PBS for 60 min and incubated with H. pylori strain
NCTC 11638 whole-cell antiserum (1:2,000) [36] for 60
min. After washing with PBS containing 0.05% Tween 20
(PBST), peroxidase-labeled goat anti-rabbit immunoglob-
lins (Dako A/S, Glostrup, Denmark) were used at 1:2,000
dilution as secondary antibodies. After washing with
PBST, the blots were developed.
Complementation of biofilm forming ability using the 
OMV
The OMV-fraction from Brucella broth supplemented
with 7% FCS (OMV-fraction) and the medium fraction
(control-fraction) in PBS were adjusted to an optical den-
sity of 2.0, or 1.0 at 280 nm. The OMV-fractions from Bru-
cella broth supplemented with 0.2% β-cyclodextrin were
also adjusted to optical densities of 1.0. After filtration,
100 μl of the fractionated OMV were added to Brucella
broth with 0.2% β-cyclodextrin for TK1402 biofilm for-
mation assays (described above).
Statistical analysis
Statistical analysis was performed using the Mann-Whit-
ney U test. P values of 0.05 or less were considered to indi-
cate statistical significance.
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